Age impacts systemic therapy outcomes in metastatic prostate cancer
Many things are evaluated when doctors are putting a treatment plan together for prostate cancer patients. A new…
PTGES3 emerges as key regulator of androgen receptor in prostate cancer
A poorly characterized protein, historically thought to be a chaperone or enzyme, may actually be a key player…
Blocking two enzymes weakens prostate tumors and boosts drug effectiveness
A major international study has uncovered a new vulnerability in prostate cancer cells that could help improve treatment…